Showing 1 to 4 of 4 rows
See Report | Preferred Variant Title | Classification | Condition | Published Date | Version | Criteria Specification | Gene |
---|---|---|---|---|---|---|---|
View | NM_000260.4(MYO7A):c.631A>G (p.Ser211Gly) | Pathogenic | Usher syndrome | 2024-07-02 | 2.0 | ClinGen Hearing Loss Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CDH23, COCH, GJB2, KCNQ4, MYO6, MYO7A, SLC26A4, TECTA and USH2A Version 2 | MYO7A |
View | NM_000260.4(MYO7A):c.631A>G (p.Ser211Gly) | Likely Pathogenic | Usher syndrome | 2020-05-12 | 1.2 | - | MYO7A |
View | NM_000260.4(MYO7A):c.631A>G (p.Ser211Gly) | Likely Pathogenic | Usher syndrome | 2020-05-12 | 1.1 | - | MYO7A |
View | NM_000260.4(MYO7A):c.631A>G (p.Ser211Gly) | Likely Pathogenic | Usher syndrome | 2020-05-12 | 1.0 | - | MYO7A |
Showing 1 to 4 of 4 rows